Investigating the difference between clinical repair and recurrence in patients with perianal fistula undergoing VAAFT surgery in two groups with and without exosome
To compare the rate of perianal fistula recurrence and the rates of clinical and radiological healing between patients receiving exosome therapy and those not receiving exosome therapy
Design
Patient will be randomly divided into two groups Intervention and Control group. Each group will consist of 20 patient. Block randomization wil be usead.
Settings and conduct
VAAFT surgery will be performed using the same standard procedure in both groups.the intervention group will receive 5 cc Exosome injection, while the control group will receive 5 cc of normal saline.The study will be designed as a Double blinde trial.the Physician and the Treatment team responsible will be unware of patients group allocation.the Patients will also be unware of the type of intervention they eeceive.
Participants/Inclusion and exclusion criteria
All patients with complex anal fistula who are treated using the VAAFT
Age between 18 and 60 years
absence of concomitant diseases (such as severe cardiovascular disease or active autoimmune diseases and IBD)
Intervention groups
Exosome injection during VAAFT in the intervention group
No Exosome injection during VAFFT surgery in the control group
Main outcome variables
Reduction in recurrence and improvement in the healing process and treatment of Perianal fistula
General information
Reason for update
Acronym
VE
IRCT registration information
IRCT registration number:IRCT20260915071064N1
Registration date:2026-09-22, 1405/06/31
Registration timing:prospective
Last update:2026-09-22, 1405/06/31
Update count:0
Registration date
2026-09-22, 1405/06/31
Registrant information
Name
Amirhossein Rahmatnejad
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 4604 1566
Email address
amirhoseinrahmatnejad@gmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2026-09-23, 1405/07/01
Expected recruitment end date
2026-10-22, 1405/07/30
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Investigating the difference between clinical repair and recurrence in patients with perianal fistula undergoing VAAFT surgery in two groups with and without exosome
Public title
Effect of Exosome in treatment of perianal fistula
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
All paitients with complex anal fistula who undergo VAAFT as the surgical treatment modality
Aged between 18 and 60 years
Absence of serious comorbidities that could affect the outcomes (such as severe heart failure or active autoimmune diseases)
Exclusion criteria:
Patients with an active systemic infection or high grade fever at the time of surgery
Patients with fistulas secondary to IBD
Presence of malignancy at the fistulasite or in other organs
Pregnancy or breastfeeding
Failure to complete the 6 months follow up or unwillingness to participate in follow up assessments
Use of immunosuppressive medications or biologic therapies within the previous 3 months
Presence of uncontrolled medical conditions or diseases such as uncontrolled diabetes mellitus that may impair the healing process
Presence of complications such as perianal sepsis or inability to undergo exosome injection
Age
From 18 years old to 60 years old
Gender
Both
Phase
N/A
Groups that have been masked
Participant
Care provider
Investigator
Outcome assessor
Sample size
Target sample size:
40
Randomization (investigator's opinion)
Randomized
Randomization description
For patient randomization in this study, block randomization will be used to ensure an equal distribution of patients btween the study groups. In this methode, blocks of a fixed size (e.g.,blocks of 4 or 6) will be designed, and the allocation of patients to the intervention and control groups within each block will be determined randmly.
This process will be performed using computuer generated randomization software to minimize any potenial allocation bias. To ensure allocation concealment, the randomization sequence will be generated by an independent individual who is not involved in the conduct of study.
The allocation codes will be placed in sealed and sequentially numbered envelopes, which will be opened only after the patient has been enrolled in the study and has provided informed consent.
This randomization method will help reduce selection bias in patient allocation and ensure a fair comparison between the study groups.
Blinding (investigator's opinion)
Double blinded
Blinding description
To minimize study bias, the study will be designed as a double-blind study. The physician and the medical team responible for administering the intervention and assessing the outcomes will be unware of the patients allocation to the two study groups. In addition, the patients themselves will be unware of the typ of intervention they receive.
Placebo
Used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethics committee of Imam Khomeini Hospital Complex of Tehran University of Medical Sciences
Street address
No 28, Biston Ave, Yusef abad
City
Tehran
Province
Tehran
Postal code
1431754333
Approval date
2025-07-29, 1404/05/07
Ethics committee reference number
IR.TUMS.IKHC.REC.1404.208
Health conditions studied
1
Description of health condition studied
Perianal Fistula
ICD-10 code
K60.3
ICD-10 code description
Anal fistula
Primary outcomes
1
Description
Percentage of patients with fistula recurrence
Timepoint
Assessment of recurrence at 3 and 6 month
Method of measurement
Examination and MRI
Secondary outcomes
empty
Intervention groups
1
Description
Intervention group: The group undergoing VAAFT surgery and Exosome injection. The intervention group will receive 5 cc of Exosome, prepared from a healty donor in the laboratory. Patient will undergo MRI imaging and clinical examination at 3 and 6 month after treatment to evaluate treatment outcomes.
Category
Treatment - Surgery
2
Description
Control group: The group undergoing VAAFT surgery without Exosome injection
Category
Treatment - Surgery
Recruitment centers
1
Recruitment center
Name of recruitment center
Imam Khomeini Hospital Complex
Full name of responsible person
Amirhossein Rahmatnejad
Street address
Imam Khomeini Hospital Complex, keshavarz blvd
City
Tehran
Province
Tehran
Postal code
1419733141
Phone
+98 21 4604 1566
Fax
+98 21 6658 1625
Email
Imamhospital@tums.ac.ir
Web page address
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
Ramin Kordi
Street address
Imam Khomeini Hospital Complex, Keshavarz Blvd
City
Tehran
Province
Tehran
Postal code
1419733141
Phone
+98 21 4604 1566
Email
ramin_kordi@tums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Tehran University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic
Person responsible for general inquiries
Contact
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
Amirhossein Rahmatnejad
Position
Resident
Latest degree
Medical doctor
Other areas of specialty/work
General Surgery
Street address
No 28, Biston Ave, Yusef abad
City
Tehran
Province
Tehran
Postal code
1431754333
Phone
+98 21 4604 1566
Email
amirhoseinrahmatnejad@gmail.com
Person responsible for scientific inquiries
Contact
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
Amirhossein Rahmatnejad
Position
resident
Latest degree
Medical doctor
Other areas of specialty/work
General Surgery
Street address
No 28, Biston Ave, Yusef abad
City
Tehran
Province
Tehran
Postal code
1431754333
Phone
+98 21 4604 1566
Email
amirhoseinrahmatnejad@gmail.com
Person responsible for updating data
Contact
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
Amirhossein Rahmatnejad
Position
resident
Latest degree
Medical doctor
Other areas of specialty/work
General Surgery
Street address
No 28, Biston Ave, Yusef abad
City
Tehran
Province
Tehran
Postal code
1431754333
Phone
+98 21 4604 1566
Email
amirhoseinrahmatnejad@gmail.com
Sharing plan
Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Yes - There is a plan to make this available
Informed Consent Form
Yes - There is a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
Yes - There is a plan to make this available
Data Dictionary
Yes - There is a plan to make this available
Title and more details about the data/document
All data can be shared after de-identifyding the individuals
When the data will become available and for how long
Access to the results after publication
To whom data/document is available
Access for researchers, universities and scientific institutions
Under which criteria data/document could be used
Use in research and scientific studies, as well as for medical purposes
From where data/document is obtainable
Dr Amirhosein Rahmatnejad
amirhoseinrahmatnejad@gmail.com
What processes are involved for a request to access data/document
Contact vai email and verfication of identity before granting access to the data